ArticleJournal of the American Chemical Society2025
Inverse Design of DNA-Programmable Protein Colloidal Crystals.
Article in Journal of the American Chemical Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Diffraction-quality, ultraflexible protein single crystals engineered with DNA.Science advances · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Protein crystals are a promising class of porous materials with applications in catalysis, encapsulation, and structural biology. However, the chemical complexity of proteins renders their crystallization a largely empirical process with variable success. In contrast, DNA-functionalized nanoparticles have been crystallized into ordered superlattices with predictable architectures using highly specific and tunable DNA-DNA interactions. Such programmability, however, has not yet been realized in protein crystals. Herein, we chemically modify protein oligomers with a DNA shell and crystallize the resulting protein-DNA conjugates using the principles of colloidal crystal engineering with DNA. When a new type of DNA design comprising three spacer-18 units and a 4-6 nucleotide sticky end was used, structures with greater crystallinity were produced (as compared to when traditional DNA designs used with inorganic assemblies were employed). Using an inverse design strategy, simple cubic, body-centered cubic (bcc), face-centered cubic (fcc), and cesium chloride (CsCl)-type lattices were synthesized by the judicious choice of DNA sequence and protein type. The resulting crystals exhibit Wulff morphologies, including those of fcc lattices, that were directly observable using optical microscopy; such morphologies are rarely achieved in the context of DNA-guided colloidal crystals and reflect the monodisperse protein building blocks. Furthermore, the annealing rate correlates with crystal growth, enabling the formation of crystals up to 80 μm in size. Given the structural, biological, and chemical diversity of natural and engineered proteins, DNA-directed protein colloidal crystallization is a powerful platform for generating a new class of programmable biomaterials with diverse structures and functionalities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.